Sivers Semiconductors: A $30 Million Glasgow Bet Against a Rising Tide of Share Dilution

Sivers Semiconductors plans $30M Glasgow fab expansion for AI lasers, but shareholder dilution and falling stock raise funding concerns.

The Swedish chipmaker's latest strategic gambit arrives with the optics of a company trying to build a cathedral while its own foundations are being excavated. Sivers Semiconductors announced Thursday that it will pour $30 million into its Glasgow fabrication facility, aiming to scale production of indium phosphide components for AI data centers — a market where demand, in management's own words, now exceeds anything previously encountered.

The expansion targets CW-DFB lasers, the light sources embedded in optical interconnects that shuttle data through AI infrastructure. Sivers wants annual capacity above 100 million units, with construction slated for the second half of 2026 and the upgraded plant expected to be operational by the fourth quarter of 2027. The move marks a deliberate shift away from the company's "fab-lite" model toward a hybrid manufacturing approach, one that will lean more heavily on Asian production partners.

The timing, however, is awkward. The announcement lands as the stock wrestles with the fallout from an aggressive sequence of capital measures that have left shareholders nursing substantial losses.

The Dilution Cascade

The pressure began building in late June when the board unveiled a directed share issue worth roughly 600 million Swedish kronor, executed through an accelerated bookbuild managed by Pareto Securities. Those new shares hit the market on July 1. Almost immediately afterward, the board authorized Bootstrap Europe IV SCSp to convert a $12 million loan into equity, resulting in the issuance of 22,847,044 new common shares. By late August, Bootstrap exercised all outstanding warrants from the existing debt financing, adding yet another layer of supply.

The cumulative effect has been punishing. Over seven trading days, the stock shed 33 percent. A more recent session brought another 10 percent decline, closing at €1.94. The shares have since recovered somewhat to €2.13, but that still leaves them 39 percent below their 50-day moving average of €3.50 — a gap that underscores how far the recovery still has to travel. At one point, the discount to the 50-day average stretched to 46 percent against a slightly higher mean of €3.59.

Insider activity has added to the noise, though with a twist. Several board members — Bami Bastani, Karin Raj, Helena Svancar, Todd Thomson, and Joakim Nideborn — completed share purchases in July as approved at the annual general meeting. Those holdings carry a minimum lock-up period of twelve months, which at least rules out near-term selling pressure from that quarter. But insider sales that followed the expiration of holding periods more than a month ago had already weighed heavily on sentiment.

A Market That Refuses to Look Up

The dilution wave has hit a company that, operationally, is making genuine progress. The interim report delivered last Sunday showed product revenues climbing 18 percent year-over-year in the second quarter, even as total revenues fell to 53.8 million Swedish kronor — a deliberate consequence of shifting away from development contracts. The opportunity pipeline grew to $1.2 billion by July, a 268 percent increase since December.

None of that has moved the needle. Since the interim report was published, the stock has dropped 20.8 percent. The market's indifference extends to other milestones as well: the announcement of an InP light source program roughly three weeks ago was followed by a 44.4 percent decline, and even the SemiNex collaboration announced in August — a $3.4 million program to develop InP light sources for AI data centers — failed to generate sustained buying interest.

Complicating the earnings picture is a non-cash accounting charge: a payroll tax provision of 42.9 million kronor, triggered by the sharp rally in the share price during the quarter, dragged adjusted EBITDA to minus 35.5 million kronor.

The Competitive Squeeze

Sivers is not alone in chasing indium phosphide capacity. Rivals are expanding their own footprints in the segment, while the multi-billion-dollar capital expenditure programs of major cloud providers continue to stoke demand for optical components. That creates a dual challenge for the Swedish firm: structural tailwinds from its target industry, but the uncomfortable reality of competing against larger, better-capitalized players with limited financial resources of its own.

The Glasgow expansion, for all its strategic logic, raises a pointed question for investors: can Sivers fund this growth trajectory without further diluting existing shareholders? Until the new facility comes online in the fourth quarter of 2027, the market will be watching whether the promised capacity translates into actual orders and revenue. The next opportunity to gauge that comes with the quarterly figures scheduled for November 26, 2026 — a date that now carries considerably more weight than the company's carefully staged announcements in between.